Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin.
about
Role of Akt signaling in resistance to DNA-targeted therapyPemetrexed induces S-phase arrest and apoptosis via a deregulated activation of Akt signaling pathway.Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinomaExtracellular signal-regulated kinase 5 and cyclic AMP response element binding protein are novel pathways inhibited by vandetanib (ZD6474) and doxorubicin in mesotheliomasThe role of interleukin-6 in malignant mesotheliomaNF2 blocks Snail-mediated p53 suppression in mesothelioma.Preclinical studies identify novel targeted pharmacological strategies for treatment of human malignant pleural mesothelioma.Molecular mechanisms underlying the antitumor activity of 3-aminopropanamide irreversible inhibitors of the epidermal growth factor receptor in non-small cell lung cancer.Malignant pleural mesothelioma: current and future perspectivesIncreasing dietary selenium elevates reducing capacity and ERK activation associated with accelerated progression of select mesothelioma tumors.Anti-angiogenic therapies for malignant pleural mesothelioma.A specific inhibitor of lactate dehydrogenase overcame the resistance toward gemcitabine in hypoxic mesothelioma cells, and modulated the expression of the human equilibrative transporter-1.miR-211 modulates gemcitabine activity through downregulation of ribonucleotide reductase and inhibits the invasive behavior of pancreatic cancer cells.Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxiaMAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1.Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines.MicroRNA-31 Regulates Chemosensitivity in Malignant Pleural MesotheliomaThe inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cellsRole of proton-coupled folate transporter in pemetrexed resistance of mesothelioma: clinical evidence and new pharmacological tools.
P2860
Q28066950-BB200E31-B1A0-45C4-8586-B45347C4BCEEQ33646091-2A42FA82-2D5B-40DB-9CE2-3CFA5E1BCB51Q34221829-CA00A1CC-7859-4E06-9F19-50638DC384E5Q34471229-77614701-19F7-4448-A36C-DE0EA4DE8E47Q35200628-0D1FE902-5806-440F-A4CF-A58D729F9B2BQ35832918-A9A740BE-51F5-44A2-9876-5DDCEAB138B1Q36159154-9D98BDCD-BE1B-4B3D-A879-3960501E1353Q36567573-09F91860-A336-4E30-910D-6F889E05972DQ37217764-C034CF62-4764-4BFB-BE98-CC8536A4C1B9Q37672887-FDDF2FC4-7F11-4749-A65D-76782F2FFDF5Q38004067-361E8E25-AB44-4B35-A87E-5254818AF627Q38728079-AAEFFB35-63E9-49A1-99AE-C53CAF07D809Q38983476-5BFE3EC2-6A65-44AF-BB25-6D05737FD478Q39068039-B0DA06F1-D948-4177-AA1D-5B5DD1A27215Q39185966-41458C9A-A6E9-4D4B-86FC-C1ACB8E3AFADQ39621469-07A0B11A-372B-4730-BCC8-B6D6377AC3B5Q41191000-D32EF745-BF72-41C4-9B5C-3332612D7D51Q42038363-0AA1DB2E-0F5D-4963-A0FA-E524B99252B7Q47747410-3C53C8B1-8A06-4191-BF9D-DD148B8764F5
P2860
Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Preclinical emergence of vande ...... th pemetrexed and carboplatin.
@en
Preclinical emergence of vande ...... th pemetrexed and carboplatin.
@nl
type
label
Preclinical emergence of vande ...... th pemetrexed and carboplatin.
@en
Preclinical emergence of vande ...... th pemetrexed and carboplatin.
@nl
prefLabel
Preclinical emergence of vande ...... th pemetrexed and carboplatin.
@en
Preclinical emergence of vande ...... th pemetrexed and carboplatin.
@nl
P2093
P2860
P356
P1476
Preclinical emergence of vande ...... th pemetrexed and carboplatin.
@en
P2093
F Giancola
G J Peters
L Gianoncelli
P A Zucali
P2860
P2888
P304
P356
10.1038/BJC.2011.400
P407
P577
2011-10-04T00:00:00Z